Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II RADPLAT for maxillary sinus cancer
jRCTs031180425Phase 2Completed
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in maxillary sinus cancer. Primary endpoint: Local control rate. Started Mar 2019; status: completed.
02
Drugs
cisplatin
03
Conditions
maxillary sinus cancer
Beyond the preview
Go deeper on jRCTs031180425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180425.